Evaluate the following multi-parameter laboratory profiles related to calcium and bone met… — USMLE Step 3

Evaluate the following multi-parameter laboratory profiles related to calcium and bone metabolism. Reference ranges: Serum Calcium $8.4-10.2$ mg/dL, Serum Phosphorus $3.0-4.5$ mg/dL, Intact PTH $15-65$ pg/mL. Match each clinical laboratory profile to its most likely underlying diagnostic etiology.

Serum Calcium: $11.8$ mg/dL, Serum Phosphorus: $2.1$ mg/dL, Intact PTH: $12$ pg/mL, PTHrP: Elevated, 1,25-dihydroxyvitamin D: NormalHumoral hypercalcemia of malignancy
Serum Calcium: $11.1$ mg/dL, Serum Phosphorus: $2.4$ mg/dL, Intact PTH: $85$ pg/mL, 24-hour urine calcium: $350$ mg/day (High)Primary hyperparathyroidism (parathyroid adenoma)
Serum Calcium: $10.9$ mg/dL, Serum Phosphorus: $3.1$ mg/dL, Intact PTH: $58$ pg/mL, Urine calcium-to-creatinine clearance ratio: $0.005$ Familial hypocalciuric hypercalcemia (FHH)
Serum Calcium: $8.4$ mg/dL, Serum Phosphorus: $5.8$ mg/dL, Intact PTH: $310$ pg/mL, estimated GFR: $18$ mL/min/1.73m $^2$ Secondary hyperparathyroidism due to chronic kidney disease
Serum Calcium: $8.1$ mg/dL, Serum Phosphorus: $2.2$ mg/dL, Intact PTH: $150$ pg/mL, 25-hydroxyvitamin D: $9$ ng/mLNutritional osteomalacia (severe vitamin D deficiency)

Cevap

Profile 1 matches Humoral hypercalcemia of malignancy. Profile 2 matches Primary hyperparathyroidism. Profile 3 matches Familial hypocalciuric hypercalcemia. Profile 4 matches Secondary hyperparathyroidism due to chronic kidney disease. Profile 5 matches Nutritional osteomalacia.

Each laboratory profile accurately maps to the diagnostic etiology by integrating calcium, phosphorus, and PTH dynamics with a definitive distinguishing variable: PTHrP for malignancy, high urine calcium for primary hyperparathyroidism, low clearance ratio for FHH, impaired GFR with high phosphorus for CKD, and deficient 25-OH-D with low phosphorus for osteomalacia.

Adım Adım Çözüm

Analyze the serum calcium levels to dichotomize the profiles into hypercalcemic (Profiles 1, 2, 3) and normo/hypocalcemic (Profiles 4, 5).

Profiles 1, 2, and 3 involve hypercalcemia. Profiles 4 and 5 involve lower calcium states driving secondary hyperparathyroidism.

Calcium level determines whether the PTH response is primary/autonomous or appropriate/compensatory.

Evaluate the intact PTH levels relative to the hypercalcemia in Profiles 1, 2, and 3.

Profile 1 has suppressed PTH, pointing to a non-parathyroid source of hypercalcemia. Profiles 2 and 3 have unsuppressed/elevated PTH, indicating a parathyroid-mediated or receptor-level etiology.

Suppressed PTH in hypercalcemia strongly suggests malignancy or vitamin D toxicity, while unsuppressed PTH requires differentiation between primary hyperparathyroidism and FHH.

Differentiate Profiles 2 and 3 using urinary calcium excretion.

Profile 2 shows high 24-hour urine calcium matching primary hyperparathyroidism, whereas Profile 3 shows a calcium-to-creatinine clearance ratio of

0.005

0.01

), diagnosing FHH.

FHH involves a mutated calcium-sensing receptor leading to increased renal tubular calcium reabsorption, unlike the hypercalciuria typically seen in primary hyperparathyroidism.

Differentiate the hypocalcemic/normocalcemic profiles (4 and 5) by examining serum phosphorus.

Profile 4 has hyperphosphatemia and low eGFR (CKD). Profile 5 has hypophosphatemia and low 25-hydroxyvitamin D (nutritional deficiency).

CKD causes phosphate retention, whereas pure vitamin D deficiency causes high PTH which aggressively excretes phosphate, leading to hypophosphatemia.

Anahtar Kavram

Interpretation of multi-parameter bone mineral profiles requires synthesizing serum calcium, phosphorus, PTH, and distinct diagnostic markers (PTHrP, urine calcium clearance, 25-OH-D, and eGFR) to accurately diagnose the underlying etiology.

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru